• 1
    Courvoisier N, Dougados M, Cantagrel A, Goupille P, Meyer O, Sibilia J, et al. Prognostic factors of 10-year radiographic outcome in early rheumatoid arthritis: a prospective study. Arthritis Res Ther 2008; 10: R106.
  • 2
    Scott DL, Smith C, Kingsley G. What are the consequences of early rheumatoid arthritis for the individual? Best Pract Res Clin Rheumatol 2005; 19: 11736.
  • 3
    Scott DL, Smith C, Kingsley G. Joint damage and disability in rheumatoid arthritis: an updated systematic review. Clin Exp Rheumatol 2003; 21 Suppl 31: S207.
  • 4
    Lindqvist E, Jonsson K, Saxne T, Eberhardt K. Course of radiographic damage over 10 years in a cohort with early rheumatoid arthritis. Ann Rheum Dis 2003; 62: 6116.
  • 5
    Korpela M, Laasonen L, Hannonen P, Kautiainen H, Leirisalo-Repo M, Hakala M, et al, for the FIN-RACo Trial Group. Retardation of joint damage in patients with early rheumatoid arthritis by initial aggressive treatment with disease-modifying antirheumatic drugs: five-year experience from the FIN-RACo study. Arthritis Rheum 2004; 50: 207281.
  • 6
    Anderson JJ, Wells G, Verhoeven AC, Felson DT. Factors predicting response to treatment in rheumatoid arthritis: the importance of disease duration. Arthritis Rheum 2000; 43: 229.
  • 7
    Combe B, Landewe R, Lukas C, Bolosiu HD, Breedveld F, Dougados M, et al. EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2007; 66: 3445.
  • 8
    Sociedad Española de Reumatología. GUIPCAR practice guideline for the management of rheumatoid arthritis. 2007. URL:
  • 9
    Aletaha D, Eberl G, Nell VP, Machold KP, Smolen JS. Attitudes to early rheumatoid arthritis: changing patterns. Results of a survey. Ann Rheum Dis 2004; 63: 126975.
  • 10
    Potter T, Mulherin D, Pugh M. Early intervention with disease-modifying therapy for rheumatoid arthritis: where do the delays occur? Rheumatology (Oxford) 2002; 41: 9535.
  • 11
    Hernandez-Garcia C, Vargas E, Abasolo L, Lajas C, Bellajdell B, Morado IC, et al. Lag time between onset of symptoms and access to rheumatology care and DMARD therapy in a cohort of patients with rheumatoid arthritis. J Rheumatol 2000; 27: 23238.
  • 12
    Carbonell J, Cobo T, Balsa A, Descalzo MA, Carmona L. The incidence of rheumatoid arthritis in Spain: results from a nationwide primary care registry. Rheumatology (Oxford) 2008; 47: 108892.
  • 13
    Richi P, Balsa A, Munoz-Fernandez S, Villaverde V, Fernandez-Prada M, Vicario JL, et al. Factors related to radiological damage in 61 Spaniards with early rheumatoid arthritis. Ann Rheum Dis 2002; 61: 2702.
  • 14
    Pincus T, Smolen JS. Early arthritis: introduction [editorial]. Clin Exp Rheumatol 2003; 21 Suppl 31: S1.
  • 15
    Villaverde V, Balsa A, Carmona L, Sanmarti R, Maese J, Pascual D, et al. What are patients with early rheumatoid arthritis like in Spain? Description of the PROAR cohort. Reumatol Clin 2009; 5: 11520. In Spanish.
  • 16
    Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 31524.
  • 17
    Rodriguez-Valverde V, Alvaro-Gracia J, Andreu Sanchez J, Batlle Gualda E, Tornero Molina J, Panel members. Second update of the consensus statement of the Spanish Society of Rheumatology on the use of biological therapies in rheumatoid arthritis. Rev Esp Reumatol 2004; 31: 394401.
  • 18
    Disease Activity Score. 2011. URL:
  • 19
    Van der Heijde D. How to read radiographs according to the Sharp/van der Heijde method. J Rheumatol 2000; 27: 2613.
  • 20
    Robins JM, Hernan MA, Brumback B. Marginal structural models and causal inference in epidemiology. Epidemiology 2000; 11: 55060.
  • 21
    Pan W. Model selection in estimating equations. Biometrics 2001; 57: 52934.
  • 22
    Finckh A, Liang MH, van Herckenrode CM, de Pablo P. Long-term impact of early treatment on radiographic progression in rheumatoid arthritis: a meta-analysis. Arthritis Rheum 2006; 55: 86472.
  • 23
    Peltomaa R, Paimela L, Helve T, Leirisalo-Repo M. Effect of treatment on the outcome of very early rheumatoid arthritis. Scand J Rheumatol 2001; 30: 1438.
  • 24
    Bukhari MA, Wiles NJ, Lunt M, Harrison BJ, Scott DG, Symmons DP, et al. Influence of disease-modifying therapy on radiographic outcome in inflammatory polyarthritis at five years: results from a large observational inception study. Arthritis Rheum 2003; 48: 4653.
  • 25
    Lard LR, Visser H, Speyer I, van der Horst-Bruinsma IE, Zwinderman AH, Breedveld FC, et al. Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies. Am J Med 2001; 111: 44651.
  • 26
    Farragher TM, Lunt M, Fu B, Bunn D, Symmons DP. Early treatment with, and time receiving, first disease-modifying antirheumatic drug predicts long-term function in patients with inflammatory polyarthritis. Ann Rheum Dis 2010; 69: 68995.
  • 27
    Uhlig T, Kvien TK, Pincus T. Test-retest reliability of disease activity core set measures and indices in rheumatoid arthritis. Ann Rheum Dis 2009; 68: 9725.
  • 28
    Kosinski M, Zhao SZ, Dedhiya S, Osterhaus JT, Ware JE Jr. Determining minimally important changes in generic and disease-specific health-related quality of life questionnaires in clinical trials of rheumatoid arthritis. Arthritis Rheum 2000; 43: 147887.
  • 29
    Aletaha D, Strand V, Smolen JS, Ward MM. Treatment-related improvement in physical function varies with duration of rheumatoid arthritis: a pooled analysis of clinical trial results. Ann Rheum Dis 2008; 67: 23843.
  • 30
    Welsing PM, Borm GF, van Riel P. Minimal clinically important difference in radiological progression of joint damage: a definition based on patient perspective. J Rheumatol 2006; 33: 5017.
  • 31
    GUIPCAR Group. Clinical practice guideline for the management of rheumatoid arthritis in Spain. Madrid: TINGS Servicios de Comunicación; 2001.
  • 32
    Consensus panel. Consensus of the Rheumatology Society on the therapy with TNF inhibitors in rheumatoid arthritis. Rev Esp Reumatol 2000; 27: 3524.
  • 33
    SER Expert Panel. Update of the Consensus of the Spanish Society of Rheumatology on Biological Therapy in Rheumatoid Arthritis. Rev Esp Reumatol 2002; 29: 515.
  • 34
    Carli C, Bridges JF, Ask J, Lindblad S. Charting the possible impact of national guidelines on the management of rheumatoid arthritis. Scand J Rheumatol 2008; 37: 18893.
  • 35
    Landewe RB, Boers M, Verhoeven AC, Westhovens R, van de Laar MA, Markusse HM, et al. COBRA combination therapy in patients with early rheumatoid arthritis: long-term structural benefits of a brief intervention. Arthritis Rheum 2002; 46: 34756.
  • 36
    Grigor C, Capell H, Stirling A, McMahon AD, Lock P, Vallance R, et al. Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial. Lancet 2004; 364: 2639.
  • 37
    Combe B. Progression in early rheumatoid arthritis. Best Pract Res Clin Rheumatol 2009; 23: 5969.
  • 38
    Quinn MA, Emery P. Window of opportunity in early rheumatoid arthritis: possibility of altering the disease process with early intervention. Clin Exp Rheumatol 2003; 21 Suppl 31: S1547.
  • 39
    Raza K, Buckley CE, Salmon M, Buckley CD. Treating very early rheumatoid arthritis. Best Pract Res Clin Rheumatol 2006; 20: 84963.
  • 40
    Verstappen SM, Jacobs JW, Bijlsma JW, Heurkens AH, van Booma-Frankfort C, Borg EJ, et al, on behalf of the Utrecht Arthritis Cohort Study Group. Five-year followup of rheumatoid arthritis patients after early treatment with disease-modifying antirheumatic drugs versus treatment according to the pyramid approach in the first year. Arthritis Rheum 2003; 48: 1797807.
  • 41
    Combe B, Benessiano J, Berenbaum F, Cantagrel A, Daures JP, Dougados M, et al. The ESPOIR cohort: a ten-year follow-up of early arthritis in France. Methodology and baseline characteristics of the 813 included patients. Joint Bone Spine 2007; 74: 4405.
  • 42
    Gonzalez-Alvaro I, Descalzo MA, Carmona L. Trends towards an improved disease state in rheumatoid arthritis over time: influence of new therapies and changes in management approach. Analysis of the EMECAR cohort. Arthritis Res Ther 2008; 10: R138.